An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure

REFERENCES

• DeBold AJ, Borenstein HB,Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intra-venous injection of atrial myocardial extract in rats. Life Sci 1981; 28: 89–94.
   Google Scholar
• Sundsfjord JA, Thibault G, Larochelle P, Cantin M. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 1988; 66: 605–10.
   PubMed Web of Science ®Google Scholar
• Itoh H, Nakao K, Sugawara A, Saito Y, Mukoyama M, Morii N, Yamada T, Shiono S, Arai H, Hosoda K, Imura H. Gamma-atrial natriuretic polypeptide [gammaANP]-derived pep-tides in human plasma: cosecretion of N-terminal gammaANP fragment and alphaANP. J Clin Endocrinol Metab 1988; 67: 429 — 37.
   Google Scholar
• Nelesen RA, Dimsdale JE, Ziegler MG. Plasma atrial natriuretic peptide is unstable under most storage conditions. Circulation 1992; 86: 463 — 6.
   Google Scholar
• Hall C, Aaberge L, Stokke 0. In vitro stability of N-terminal proatrial natriuretic factor in unfrozen samples: an important prerequisite for its use as a biochemical parameter of atrial pressure in clinical routine. Circulation 1995; 91: 911.
   Google Scholar
• Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78–81.
   PubMed Web of Science ®Google Scholar
• Saito Y, Nakao K, Itoh H, Yamada T, Mukoyama M, Arai H, Hosoda K, Shirakami G, Suga S, Minamino N, Kangawa K, Matsuo H, Imura H. Brain natriuretic peptide is a novel cardiac hor-mone. Biochem Biophys Res Commun 1989; 158: 360 — 8.
   PubMed Web of Science ®Google Scholar
• Kambayashi Y, Nakao K, Mukoyama M, Saito Y, Ogawa Y, Shiono S, Inouye K, Yoshida N, Imura H. Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett 1990; 259: 341 — 5.
   Google Scholar
• Hino J, Tateyama H, Minamino N, Kangawa K, Matsuo H. Isolation and identification of human brain natriuretic peptides in cardiac atrium. Bio-chem Biophys Res Commun 1990; 167: 693–700.
   PubMed Web of Science ®Google Scholar
• Mukoyama M, Nakao K, Obata K, Jougasaki M, Yoshimura M, Morita E, Hosoda K, Suga S, Ogawa Y, Yasue H, Imura H. Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun 1991; 180: 431 —6.
   PubMed Web of Science ®Google Scholar
• Yoshimura M, Yasue H, Okumura K, Ogawa H, Jougasaki M, Mukoyama M, Nakao K, Imura H. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993; 87: 464 — 9.
   PubMed Web of Science ®Google Scholar
• Kohno M, Horio T, Toda I, Akioka K, Tahara A, Teragaki M, Takeuchi K, Kurihara N, Takeda T. Cosecretion of atrial and brain natriuretic peptides during supraventricular tachyarrhythmias. Am Heart J 1992; 123: 1382 — 4.
   Google Scholar
• Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K. Localization and mechanism of secretion of B-type natriuretic pep-tide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195 — 203.
   PubMed Web of Science ®Google Scholar
• Mathisen P, Hall C, Simonsen S. Comparative study of atrial peptides ANP[1-98] and ANP[99-126] as diagnostic markers of atrial distension in patients with cardiac disease. Scand J Clin Lab Invest 1993; 53: 41–9.
   Google Scholar
• Nakamura M, Kawata Y, Yoshida H, Arakawa N, Koeda T, Ichikawa T, Funakoshi T, Hiramori K. Relationship between plasma atrial and brain natriuretic peptide concentration and hemo-dynamic parameters during percutaneous trans-venous mitral valvulotomy in patients with mitral stenosis. Am Heart J 1992; 124: 1283 — 8.
   PubMed Web of Science ®Google Scholar
• Haug C, Metzele A, Kochs M, Hombach V, Grfinert A. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure. Clin Cardiol 1993; 16: 553–7.
   Google Scholar
• Omland T, Aakvaag A, Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ven-tricular impairment. Heart 1996; 76: 232–7.
   Google Scholar
• Muders F, Kromer EP, Griese DP, Pfeifer M, Hense HW, Riegger GAJ, Elsner D. Evaluation of plasma natriuretic peptides as markers for left ven-tricular dysfunction. Am Heart J 1997; 134: 442–9.
   Google Scholar
• Klinge R, Djoseland 0, Karlberg BE, Hall C. Car-diac secretion of atrial and brain natriuretic pep-tides in acute ischemic heart failure in pigs: effect of angiotensin II receptor antagonism. Clin Physiol 1997; 17: 389–400.
   Google Scholar
• Hall C, Karlberg BE. Plasma concentrations of angiotensin II and aldosterone during acute left ventricular failure in the dog. Effect of converting enzyme inhibition. Res Exp Med 1986; 186: 387 — 95.
   Google Scholar
• Spinale FG, Hendrick DA, Crawford FA, Smith AC, Hamada Y, Carabello BA. Chronic supraven-tricular tachycardia causes ventricular dysfunction and subendocardial injury in swine. Am J Physiol 1990; 259: H218–29.
   PubMed Web of Science ®Google Scholar
• Wilson JR, Douglas P, Hickey WF, Lanoce V, Ferraro N, Muhammad A, Reichek N. Experimen-tal congestive heart failure produced by rapid ven-tricular pacing in the dog: cardiac effects. Circulation 1987; 75: 857 — 67.
   Google Scholar
• Helmer GA, McKirnan MD, Shabetai R, Boss GR, Ross Jr J, Hammond HK. Regional deficits of myo-cardial blood flow and function in left ventricular pacing-induced heart failure. Circulation 1996; 94: 2260 —7.
   PubMed Web of Science ®Google Scholar
• Packer M. Pathophysiology of chronic heart failure. Lancet 1992; 340: 88 — 92.
   PubMed Web of Science ®Google Scholar
• Christensen G, Leistad E. Atrial systolic pressure, as well as stretch, is a principal stimulus for release of ANF. Am J Physiol 1997; 272: H820 — 6.
   PubMed Web of Science ®Google Scholar
• Naruse M, Takeyama Y, Tanabe A, Hiroshige J, Naruse K, Yoshimoto T, Tanaka M, Katagiri T, Demura H. Atrial and brain natriuretic peptides in cardiovascular diseases. Hypertension 1994; 23 Suppl I: 231–4.
   Google Scholar
• Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosada K, Suga S, Shirakami G, Jougasaki M, Imura H. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 1990; 323: 757–8.
   Google Scholar
• Riegger GAJ, Elsner D, Kromer EP, Daffner C, Forssmann WG, Muders F, Pascher EW, Kochsiek K. Atrial natriuretic peptide in conges-tive heart failure in the dog: plasma levels, cGMP, ultrastructure of atrial myoendocrine cells, and hemodynamic hormonal and renal effects. Circula-tion 1988; 77: 398 — 406.
   PubMed Web of Science ®Google Scholar